Clinical Trial Update: Comparing Immunogenicity and Safety of Different Formulations of HBV-MPL Vaccine With Engerix™-B in Adults Aged 19-40 y [Phase 2]

View source ↗

Summary

A Phase 2 trial update comparing immunogenicity and safety of different formulations of an HBV-MPL vaccine with Engerix-B in adults aged 19-40; the study is com…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Hepatitis B

Drugs mentioned

• Engerix-B (hepatitis B vaccine)
• HBV-MPL vaccine (HBV-MPL vaccine)

Snippet

Sponsor: GlaxoSmithKline | Conditions: Hepatitis B | Phase 2 | Status: COMPLETED